Literature DB >> 8592082

Secretory phospholipase A2 activity is required for permeability barrier homeostasis.

M Mao-Qiang1, M Jain, K R Feingold, P M Elias.   

Abstract

The extracellular bilayers which mediate the epidermal permeability barrier are enriched in ceramides, free fatty acids, and cholesterol. Yet, the epidermal lamellar body, the source of these lipids, is enriched in a more polar mixture; i.e., glucosylceramides and phospholipids, which it delivers to the stratum corneum (SC) interstices. Whereas the extracellular processing of glucosylceramides to ceramides has been shown to be required for barrier homeostasis, the requirement for phospholipid degradation to free fatty acids is not yet established. In this study, we ascertained that topical applications of two chemically unrelated inhibitors of secretory phospholipase A2 (PLA2), bromphenacyl bromide and MJ-33, produced a progressive perturbation in barrier function in intact murine skin, first appearing at 5 d, preceded by the development of epidermal hyperplasia. Moreover, the defect in barrier homeostasis could be reversed by topical co-applications of the nonessential fatty acid, and of palmitic acid, but not by linoleic acid, both products of phospholipid catabolism. Furthermore, the barrier abnormality was accompanied by a reduction in free fatty acid levels in the stratum corneum, while phospholipid levels remained unchanged. These biochemical alterations were accompanied by the appearance of immature, incompletely processed lamellar body-derived membranes in the SC interstices, and depletion of histochemically detectable neutral lipid. Both the abnormalities and the epidermal hyperplasia were reversed by co-applications of palmitic acid (but not linoleic acid) with either inhibitor. These results demonstrate that processing of phospholipids to nonessential free fatty acids, by a yet-to-be-identified extracellular phospholipase, is required for the maintenance of barrier homeostasis in intact skin. Furthermore, our studies show that the barrier abnormalities induced by the PLA2 inhibitors are due to a failure to generate free fatty acids rather than to phospholipid accumulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592082     DOI: 10.1111/1523-1747.ep12327246

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

1.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Authors:  Mao-Qiang Man; Yutaka Hatano; Seung H Lee; Mona Man; Sandra Chang; Kenneth R Feingold; Donald Y M Leung; Walter Holleran; Yoshikazu Uchida; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

2.  Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.

Authors:  George Man; Theodora M Mauro; Peggy L Kim; Melanie Hupe; Yongjiao Zhai; Richard Sun; Debbie Crumrine; Carolyn Cheung; Almudena Nuno-Gonzalez; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2014-07-31       Impact factor: 3.960

3.  Stratum corneum acidification: how and why?

Authors:  Peter M Elias
Journal:  Exp Dermatol       Date:  2015-02-17       Impact factor: 3.960

4.  The acyl-CoA binding protein is required for normal epidermal barrier function in mice.

Authors:  Maria Bloksgaard; Signe Bek; Ann-Britt Marcher; Ditte Neess; Jonathan Brewer; Hans Kristian Hannibal-Bach; Torben Helledie; Christina Fenger; Marianne Due; Zane Berzina; Reinhard Neubert; John Chemnitz; Bente Finsen; Anders Clemmensen; Johannes Wilbertz; Henrik Saxtorph; Jens Knudsen; Luis Bagatolli; Susanne Mandrup
Journal:  J Lipid Res       Date:  2012-07-24       Impact factor: 5.922

5.  Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin.

Authors:  Kei Yamamoto; Yoshitaka Taketomi; Yuki Isogai; Yoshimi Miki; Hiroyasu Sato; Seiko Masuda; Yasumasa Nishito; Kiyokazu Morioka; Yoshikazu Ishimoto; Noriko Suzuki; Yasunori Yokota; Kohji Hanasaki; Yukio Ishikawa; Toshiharu Ishii; Tetsuyuki Kobayashi; Kiyoko Fukami; Kazutaka Ikeda; Hiroki Nakanishi; Ryo Taguchi; Makoto Murakami
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

6.  Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intracellular killing of Staphylococcus aureus by human monocytes.

Authors:  L Zheng; T P Zomerdijk; M T Van Den Barselaar; M F Geertsma; R Van Furth; P H Nibbering
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

7.  Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation.

Authors:  Olga Golonzhka; Xiaobo Liang; Nadia Messaddeq; Jean-Marc Bornert; Adam L Campbell; Daniel Metzger; Pierre Chambon; Gitali Ganguli-Indra; Mark Leid; Arup K Indra
Journal:  J Invest Dermatol       Date:  2008-12-18       Impact factor: 8.551

8.  Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.

Authors:  Joachim W Fluhr; Mao-Qiang Man; Jean-Pierre Hachem; Debra Crumrine; Theodora M Mauro; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2008-08-14       Impact factor: 8.551

9.  sPLA2 and the epidermal barrier.

Authors:  Dusko Ilic; James M Bollinger; Michael Gelb; Theodora M Mauro
Journal:  Biochim Biophys Acta       Date:  2013-11-20

10.  Expression and Function of Group IIE Phospholipase A2 in Mouse Skin.

Authors:  Kei Yamamoto; Yoshimi Miki; Hiroyasu Sato; Yasumasa Nishito; Michael H Gelb; Yoshitaka Taketomi; Makoto Murakami
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.